US Patent Issued to The Johns Hopkins University, Federal University of Rio De Janeiro on Sept. 29 for "Nanosuspension formulation for treatment of pulmonary fibrosis" (Brazilian, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,210, issued on Sept. 29, was assigned to The Johns Hopkins University (Baltimore) and Federal University of Rio De Janeiro (Rio de Janeiro, Brazil).

"Nanosuspension formulation for treatment of pulmonary fibrosis" was invented by Jung Soo Suk (Clarksville, Md.), Luisa Helena Andrade Da Silva (Rio de Janeiro, Brazil), Patricia Rocco (Rio de Janeiro, Brazil) and Marcelo Morales (Rio de Janeiro, Brazil).

According to the abstract* released by the U.S. Patent & Trademark Office: "An inhalable nanocrystal-based suspension formulation of nintedanib (NTB) (NTB-NS) possessing specific physicochemical properties to enhance drug retention in the lung was developed for localized treatment ...